Chief Executive Officer, Chief Financial Officer; Board Chairman

Mr. Ehrlich is a co-founder of Innovation and serves as Chief Financial Officer and Chief Executive Officer for the company. He also is Board Chairman. Mr. Ehrlich has over 25 years of executive leadership experience in building and managing emerging growth companies. Prior to joining Innovation, Mr. Ehrlich served as Chief Financial Officer and Director of Nanoviricides, a publicly-traded company developing nanotechnology-based anti-viral medicines. Mr. Ehrlich also served in various management roles—as CEO, President, CFO, Director—while at StatSure Diagnostic Systems, Inc., a diagnostic specialty firm with a focus on HIV testing. Mr. Ehrlich is a Certified Public Accountant and received a BBA degree from Bernard Baruch College of the City University of New York. 


Krishna Menon, PhD, VMD

Former Chief Scientific Officer, President of Research; Board Member

Dr. Menon is a co-founder of Innovation, serving as Chief Scientific Officer, and Board Member. He is a leading pharmaceutical scientist with over 30 years of drug development experience in academia and industry. Prior to Innovation, Dr. Menon served at Eli Lilly as Group Leader, Cancer In Vivo Research and Clinical Development. While there, Dr. Menon played an integral role in lead selection and pre-clinical development of Gemzar and Alimta, two blockbuster oncology drugs. He was awarded Eli Lilly’s prestigious President’s Recognition Award. Earlier in his professional career, he held research scientist positions at Miles Laboratories and Dana Farber Cancer Research Institute. Dr. Menon is a trained veterinary surgeon (VMD) and holds a PhD (Pharmacology) from Kerala University.  


Barry SchecHter, MD, FAAO

Independent Board Member

Dr. Schechter is the Director of Department of Cornea and External Disease at Florida Eye Microsurgical Institute. Prior, he was co-founder and Chief Executive Officer (CEO) of Pediavision, a company dedicated to saving children’s eyesight. He also is a consultant for Gerson Lehrman Group. Dr. Schechter’s clinical focus involves diseases of the ocular surface, including dry eyes, allergies, infection, corneal, refractive and cataract surgery, and glaucoma. He also serves on the Editorial Board for Advanced Ocular Care. Dr. Schechter has reviewed numerous articles for leading ophthalmology journals, lectures worldwide, and consults for various pharmaceutical companies. Dr. Schechter graduated from City University of New York and Brooklyn College, and received a MD from SUNY Downstate Medical Center. 


Zorik Spektor, MD, FAAP

Independent Board Member

Dr. Spektor is a Fellowship-trained and Board-certified Pediatric Otolaryngologist and Head and Neck Surgeon. He has served on advisory boards for several medical device and pharmaceutical companies and been involved in significant advances in his field. Dr. Spektor currently serves as Director of The Center for Pediatric ENT – Head and Neck Surgery, in Boynton, Florida. He is also a Voluntary Assistant Professor of Surgery at the Department of Otolaryngology, University of Miami, and an Affiliate Clinical Assistant Professor of Biomedical Science at Florida Atlantic University. He is a Fellow of the American Academy of Otolaryngology – Head and Neck Surgery and American Academy of Pediatrics. Dr. Spektor received a BS from Cornell University, and a MD from Albany Medical College of Union University. 


Mark R. Tobin, MBA

Independent Board Member

Mark Tobin is the Senior Director, Corporate Strategy at Printronix, LLC, a leading manufacturer of industrial printers. From 2013 to 2017, Mr. Tobin served in various roles of increasing responsibility with NanoFlex Power Corporation, a publicly-listed advanced solar technology company, culminating as Executive Vice President and Chief Financial Officer. From 2013 to 2015, Mr. Tobin served as a Managing Director at Digital Offering, a merchant bank. Previously, from 2005 to 2013, he served as Director of Research and as a Senior Research Analyst at Roth Capital Partners, a leading boutique investment bank, where he oversaw equity research on hundreds of small-cap public companies across a variety of sectors. Prior to that, he was a Program Manager and Senior Systems Engineer at Science Applications International Corporation, a FORTUNE 500® scientific, engineering, and technology applications company. Mr. Tobin began his career as an officer in the United States Air Force, overseeing advanced technology development programs and representing the U.S. as a NATO delegate, and ultimately achieving the rank of Major. He graduated with honors from the U.S. Air Force Academy with a Bachelor’s of Science in Management and received an MBA from the University of Pittsburgh.